Science Explorer Back to mapMap
Discussion
Researcher · Rosetta Stone (United States) · United States

Michael O. Carleton

Michael O. Carleton publishes mostly in Molecular Biology, Immunology and Oncology, on topics such as Immune Cell Function and Interaction, T-cell and B-cell Immunology and MicroRNA in disease regulation.

OpenAlex
World rank
#515,103
of 7,710,434 ranked researchers
Rank in United States
#179,078
of 1,627,098
Works
65
Citations
6.3k
Citations per work
97.3
h-index
27
i10-index 33Top 19% in Molecular Biology
Michael O. Carleton

What does Michael O. Carleton research?

Michael O. Carleton's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Immunology and Microbiology (23%), Medicine (17%).

Life Sciences: 34 works · 52.6% of their workBiochemistry, Genetics and Molecular Biology: 20 works · 30.0% of their workMolecular Biology: 15 works · 23.4% of their workCancer Research: 4 works · 6.6% of their workImmunology and Microbiology: 15 works · 22.6% of their workImmunology: 15 works · 22.6% of their workEverything else: 20 works · 30.6% of their workHealth Sciences: 11 works · 16.8% of their workMedicine: 11 works · 16.8% of their workOncology: 6 works · 9.5% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 4.4% of their workGenetics: 2 works · 2.9% of their workTHEIR WORKMichael O.Carleton65works
Life Sciences53%Health Sciences17%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology2030.0%
    2. Immunology and Microbiology1522.6%
  2. Everything else2030.6%
    1. Medicine1116.8%
  1. 1Molecular Biology23% of their works
  2. 2Immunology23% of their works
  3. 3Oncology10% of their works
  4. 4Cancer Research7% of their works
  5. 5Radiology, Nuclear Medicine and Imaging4% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Michael O. Carleton's research?

The keywords of their largest research topics: Cancer, Immunity, Foxp3, Natural Killer Cells, NK Cell Recognition, TGF-ß, Gene Expression and Immune Checkpoint Blockade.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer112 topics
  2. Immunity102 topics
  3. Foxp381 topic
  4. NK Cell Recognition81 topic
  5. Natural Killer Cells81 topic
  6. TGF-ß81 topic
  7. Gene Expression61 topic
  8. Immune Checkpoint Blockade61 topic
  9. MicroRNA61 topic
  10. PD-1 and PD-L161 topic
  11. Activation51 topic
  12. Cancer Immunotherapy51 topic
  13. Dendritic Cells51 topic
  14. Genome Engineering51 topic
  15. Macrophage51 topic
  16. RNA-Guided51 topic
  17. Glioblastoma41 topic
  18. Temozolomide41 topic

Where does Michael O. Carleton work?

Michael O. Carleton's main affiliation in the publication record is Rosetta Stone (United States), United States.

How many publications and citations does Michael O. Carleton have?

OpenAlex counts 65 works and 6,322 citations for Michael O. Carleton, an h-index of 27, ranking #515,103 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael O. Carleton. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.